Indegene Ltd Q4 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Indegene Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Indegene Ltd management said on order book — free account, 30 seconds.
Capex plans
Track Indegene Ltd — get its next earnings analysis in your feed
How does Indegene Ltd rank vs peers in Healthcare Services?
Pro featureHow does Indegene Ltd rank in Healthcare Services?
Compare Indegene Ltd against every Healthcare Services company (Q4 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Indegene Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio
- Aatmaj Healthcare Ltd (Q2 FY27)
Revenue from operations for H1 FY 26-27: ₹1,695.98 million vs ₹1,081.04 million in H1 FY 25-26, reflecting a 54% growth (Page 13 & 14). Key investor presentatio